Synairgen (LON:SNG) Share Price Crosses Below 200-Day Moving Average – What’s Next?

Synairgen plc (LON:SNG)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4.75 ($0.06) and traded as low as GBX 4.40 ($0.06). Synairgen shares last traded at GBX 4.59 ($0.06), with a volume of 14,340 shares trading hands.

Synairgen Stock Down 0.6 %

The company has a market capitalization of £9.24 million, a PE ratio of -153.00 and a beta of -2.23. The company’s fifty day moving average is GBX 4.20 and its 200-day moving average is GBX 4.75. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77.

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.